Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives

Immunotherapy may result in long-lasting exceptional clinical responses, the molecular background of which is inadequately understood. Here, we present the case of a 63-year-old patient with a past medical history of renal cancer who relapsed many years later. Several treatment lines were administer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Dimitrakopoulos, Foteinos-Ioannis D., Kourea, Eleni, Nasioulas, George, Papadopoulou, Eirini, Nikolakopoulos, Achilles, Spyropoulou, Despoina, Kottorou, Anastasia, Karatzas, Andreas, Kalofonos, Haralabos P., Koutras, Angelos
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425249/
https://ncbi.nlm.nih.gov/pubmed/32849917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920946152
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars